Post written by iGIE Editor-in-Chief Linda Lee, MD, FACG, FASGE, and Senior Associate Editors Hiroyuki Aihara, MD, PHD, FASGE, FACG, FJGES, Phillip Ge, MD, and Marvin Ryou, MD. We invite all authors to submit their original research, pilot studies, reviews, meta-analyses, case reports, and images to iGIE. Our fee waiver is in effect through 11:59PM …
Continue reading Submit manuscripts to iGIE for free in 2025
Post written by Lady Katherine Mejia Perez, MD, and Kyungran Justina Cho, MD, PhD, from the Department of Gastroenterology, Hepatology and Nutrition, Cleveland Clinic, Erica Savage, MD, from the Department of Pathology and Laboratory Medicine, Cleveland Clinic, and Amit Bhatt, MD, from the Department of Gastroenterology, Hepatology and Nutrition, Cleveland Clinic, Cleveland, Ohio, USA. We describe a unique case of a large well-differentiated gastric …
Continue reading Endoscopic submucosal dissection of a gastric adenocarcinoma of fundic-gland type
Post written by M. Ammar Kalas, MD, from Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA. This study aimed to assess the effect of a through-the-scope balloon attachment on depth of maximal ileal insertion (DMI) during retrograde enteroscopy. We adopted a crossover trial design in which each patient in the study …
Post written by Suchapa Arayakarnkul, MD, from the Department of Medicine, University of Minnesota, Minneapolis, and Daniela Guerrero Vinsard, MD, from the Division of Gastroenterology and Hepatology, Minneapolis VA Medical Center, Minneapolis, and Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis, Minnesota, USA. We present a case of gastric adenocarcinoma and proximal polyposis syndrome (GAPPS) and review its …
Continue reading Bridge the GAPPS (gastric adenocarcinoma and proximal polyposis syndrome)
Post written by Bo Shen, MD, from Columbia University Irving Medical Center/New York Presbyterian Hospital, New York, New York, and Phillip S. Ge, MD, from the University of Texas MD Anderson Cancer Center, Houston, Texas, USA. This article describes the evolution of the field of interventional inflammatory bowel disease (IBD), ie, endoscopic management of structural adverse events of IBD, …
Continue reading Bringing therapeutic endoscopy to the world of inflammatory bowel disease
Post written by Abdulrahman Qatomah, MBBS, FRCPC, from Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA, and King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia. A 65-year-old woman with a history of Roux-en-Y gastric bypass presented with cholangitis secondary to a benign biliary stricture. She previously underwent placement of a percutaneously …
Post written by Yang-Bor Lu, MD, from the Department of Digestive Diseases, Digestive Endoscopy Center, Xiamen Chang Gung Hospital, Xiamen, China. We performed single-operator endoscopic direct appendiceal therapy (EDAT) by first using a slim endoscopic ultrasound (EUS) miniprobe (Olympus UM-2R, Tokyo, Japan) to map the appendiceal axis then steering a disposable cholangioscope (VedVision, TY-ISS-L31; Vedkang, …
Post written by Yervant Ichkhanian, MD, and Mark A. Gromski, MD, from the Indiana University School of Medicine, Indianapolis, Indiana, USA. Duodenoscope-related infections—especially those involving multidrug-resistant organisms—have driven innovation in endoscopic technology. This study, conducted at a high-volume tertiary care center, explores the evolving integration of single-use duodenoscopes into routine endoscopic retrograde cholangiopancreatography (ERCP) practice. The goal was to examine, over …
Post written by Christina Gainey, MD, from the University of North Carolina, Chapel Hill, North Carolina, USA. We wanted to study the feasibility, safety, and effectiveness of performing endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound (EUS)—guided gallbladder drainage (EUS-GBD) in a single session to provide definitive management of biliary obstruction and prevent future biliary adverse events without …
Post written by Benjamin Norton, MD, from Cleveland Clinic London, London, United Kingdom. We are currently experiencing an obesity and diabetic epidemic. We know that the number of people living with type 2 diabetes (T2D) is expected to rise worldwide to alarming rates (1.31 billion by 2050).1 We are seeing an explosion in the number …
endoscopedia.com 